Senior insider sale
TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.19M
14.76K shares
What this filing means
LIN ELIZABETH YEU plans to sell 14.76K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $1.19M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/4/2026ACC: 0001959173-26-006760
Director
Since Dec 2021
14.76K
Shares to sell
$1.19M
Approx. market value
3.18K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Open Market Purchase
Cash
9/14/2022
3.18KTotal acquired3.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/14/2022 | Open Market Purchase Cash | 3.18K | — |
| Total | 3.18K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1.59K
Market value
$127.2K
9/2/2026
—Completed
Units to sell
5.39K
Market value
$446.0K
9/2/2026
—Completed
Units to sell
4.60K
Market value
$339.8K
9/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.18K
Market value
$278.3K
9/4/2026
Total
Units
14.76K
Value
$1.19M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/2/2026 | 1.59K | $127.2K | — | Completed |
9/2/2026 | 5.39K | $446.0K | — | Completed |
9/1/2026 | 4.60K | $339.8K | — | Completed |
| Planned — Approximate Date | ||||
9/4/2026 | 3.18K | $278.3K | NASDAQ | Planned |
| Total | 14.76K | $1.19M | ||